Toronto Memory Program

02/24/2026

This week, the Canadian Drug Expert Committee issued a draft recommendation against public reimbursement of lecanemab (Leqembi) for patients with mild cognitive impairment or mild dementia due to early Alzheimer’s disease.

In a recent interview, our Medical Director, Dr. Sharon Cohen, discusses the clinical trial data, cost considerations, and what this recommendation could mean for patients and families.

Watch the full report here:

The Canadian Drug Expert Committee (CDEC) this week recommended that lecanemab, commonly referred to as Leqembi, should not be reimbursed for the treatment o...

02/12/2026

The TRAVELLER study seeks to identify people who are best suited to participate in one of Roche’s Alzheimer’s disease clinical studies. This study also aims to engage with diverse communities to ensure we include all people living with Alzheimer’s disease.

02/06/2026

A Night of Celebration & Progress!

We were proud to join Sentrex in celebrating the grand opening of their new North York PerCuro Infusion Centre. The centre was specifically designed to provide infusions for individuals with Alzheimer’s disease.

This special evening brought together healthcare professionals, community partners, representatives from the Alzheimer Society of Toronto and other organizations, patients, and staff.

The event celebrated a major milestone: the approval of Canada’s first disease-slowing therapy for Alzheimer’s disease, lecanemab, and the opening of a new onsite infusion centre within our shared building—expanding access for patients to receive treatment in a familiar, supportive setting.

We’re excited to share that patients have already started receiving treatment, making this moment even more impactful. The ribbon cutting was especially meaningful as we celebrated alongside a participant in the pivotal clinical trial that showed the efficacy of lecanemab in slowing disease progression.

Thank you to Percuro and Sentrex for their collaboration and shared commitment to advancing patient-centred care.

An unforgettable night—and an exciting step forward for our community.

02/03/2026

Do You Want To Make A Difference In Alzheimer’s Research?

The Bio-Hermes-002 research study seeks volunteers with or without memory concerns to help identify blood or digital tests that could help predict the presence of amyloid plaques or tau tangles in the brain, which are the hallmarks of Alzheimer’s disease.

To learn more: https://globalalzplatform.org/biohermes-002study/

01/26/2026

We’re proud to share an important milestone in Alzheimer’s disease care in Canada.

Last week, Toronto Memory Program, in partnership with PerCuro by Sentrex, supported one of the first infusions of a newly approved treatment in the country.

This moment marks the introduction of Canada’s first disease-slowing therapy for Alzheimer’s disease, opening a new chapter in care for patients and their families.

01/15/2026

Dr. Kore Kai Liow, Neurologist and Researcher at the Hawaii Memory Disorders Center and Alzheimer’s Research Unit, speaks about an ongoing Roche-sponsored clinical trial studying trontinemab in people with early symptomatic Alzheimer’s disease. The discussion highlights how this investigational therapy uses Roche’s Brainshuttle technology to improve delivery of anti-amyloid antibodies across the blood–brain barrier, with the goal of achieving more effective amyloid clearance in the brain. Watch to learn more about the science behind trontinemab and the importance of clinical research in advancing Alzheimer’s disease treatment and care.

Kore Kai Liow, MD, Neurologist and Reseacher at Hawaii Memory Disorders Center and Alzheimer's Research Unit, Honolulu explained to Sara Mattison, News Anch...

12/30/2025

Trontinemab is one of the latest disease-modifying drugs currently being tested in late-stage clinical trials. Here’s what we know about this potential new treatment for Alzheimer's disease.

12/18/2025

🎄 Holiday Hours at Toronto Memory Program 🎄

Please note that TMP will be closed on Christmas Day, Boxing Day, and New Year’s Day.

We wish you and your loved ones a wonderful holiday season filled with warmth, health, and joy. 💫

12/04/2025

Making healthy choices can help you avoid many chronic diseases and can even lower your risk of severe illness from some infectious diseases, such as the flu and COVID-19. But healthy behaviors are only part of the picture. Getting routine preventive care can help you stay well and catch problems early.

Knowing your family health history can help you stay well and catch problems early.

11/27/2025

It’s not quite winter yet, but it is sure starting to look like it. As the colder weather sets in, many older adults find it harder to stay active and connected — but this time of year also brings wonderful opportunities to enjoy safe, meaningful, and enriching activities.

Here are a variety of ideas to stay engaged this season:
• Short outdoor walks on clear days
• Feeding winter birds
• Indoor stretching, yoga, or gentle exercise videos
• Cooking, baking, or trying a new winter recipe
• Reading, audiobooks, or joining a book club
• Puzzles, crosswords, card games, or board games
• Knitting, sewing, or other creative crafts
• Painting, drawing, or adult colouring
• Organizing old photos or creating a memory album
• Listening to music or learning a musical instrument
• Journaling or writing letters to loved ones
• Virtual or phone catch-ups with friends and family
• Watching documentaries or educational series
• Exploring online classes in history, languages, or art
• Indoor gardening or caring for houseplants

Small, enjoyable activities can make the months ahead brighter and support both physical and cognitive health.

11/18/2025

On November 12, 2025, Dr. Sharon Cohen—Founder and Medical Director of Toronto Memory Program—joined the Alzheimer Society of Huron-Perth to deliver her talk, “A New Era: 2025 Update on Diagnosis and Treatment of Alzheimer’s Disease.” Dr. Cohen provided a comprehensive update on emerging research that is reshaping the dementia treatment landscape in Canada.

In her presentation, she discussed the progression and risk factors for dementia, promising new treatments currently in Phase III clinical trials, the impact of brain-healthy lifestyle choices, and the critical importance of participation in clinical trials.

Alzheimer Society Huron Perth - 2025 Dementia Research Night. On November 12, 2025, Dr. Sharon Cohen, founder and Medical Director of the Toronto Memory Prog...

11/13/2025

Today, our Medical Director and Behavioural Neurologist, Dr. Sharon Cohen, had the pleasure of presenting to the wonderful community at Extended Learning Opportunities (ELO) in Erin, Ontario — a volunteer-run lifelong learning group dedicated to bringing educational events to their community.

Dr. Cohen delivered A New Era: 2025 Update on Alzheimer’s Diagnosis & Treatment — a timely and inspiring session highlighting how far we’ve come in understanding, diagnosing, and treating Alzheimer’s disease.

With Canada’s first disease-slowing treatment for Alzheimer’s now approved, this truly is a historic moment. More individuals are seeking early assessment, new diagnostic tools (including blood tests) are becoming available, and community education has never been more important.

We loved connecting with this thoughtful, engaged audience and having the chance to answer their questions.

A meaningful day of learning, hope, and progress — and we’re grateful to be part of it.